Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 1;67(Pt 4):o914-5.
doi: 10.1107/S1600536811009603. Epub 2011 Mar 19.

N-[2-(4-Bromo-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide

N-[2-(4-Bromo-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide

Mehmet Akkurt et al. Acta Crystallogr Sect E Struct Rep Online. .

Abstract

In the title compound, C(16)H(14)BrN(3)O(2)S, the atoms of the 1,3-thia-zolidine group, except for the N and the C atoms attached to the bromo-benzene ring, are disordered over two sets of sites with occupancies of 0.605 (13) and 0.395 (13). The benzene and pyridine rings make a dihedral angle of 86.2 (2)°. In the crystal, mol-ecules are linked by inter-molecular N-H⋯N and C-H⋯O hydrogen bonds, forming a three-dimensional network. Furthermore, there is a π-π stacking inter-action [centroid-centroid distance = 3.758 (2) Å] between the pyridine and benzene rings.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The title molecule with the atom numbering scheme. Displacement ellipsoids for non-H atoms are drawn at the 30% probability level. Only the major component of the disorder is shown.
Fig. 2.
Fig. 2.
The packing and hydrogen bonding interactions viewed down the c axis. All hydrogen atoms not involved in hydrogen bonding and the minor component of the disorder have been omitted for clarity.

References

    1. Abdel-Alim, A. M., El-Shorbagi, A. A., Abdel-Mothy, S. G. & Abdel-Allah, H. H. M. (2005). Arch. Pharm. Res. 28, 637–647. - PubMed
    1. Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115–119.
    1. Barreca, M. L., Chimirri, A., De Clercq, E., De Luca, L., Monforte, A. M., Monforte, P., Rao, A. & Zappala, M. (2003). Farmaco, 58, 259–263. - PubMed
    1. Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
    1. Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837–838.